← Back to Search

Artificial Disc Replacement

Prodisc C SK & Vivo vs. Mobi-C for Cervical Disc Disease (SMART Trial)

N/A
Recruiting
Research Sponsored by Centinel Spine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of radiculopathy or myelopathy with radiculopathy of the cervical spine, with pain, paresthesias or paralysis in a specific nerve root distribution C3 through C7, including at least one of the following: Symptomatic cervical disc disease (SCDD) at two contiguous levels from C3 to C7.
Radiographically determined pathology at the level to be treated correlating to primary symptoms.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

SMART Trial Summary

This trial is testing two different types of disc replacements against a similar device that is already on the market.

Who is the study for?
This trial is for adults aged 18-69 with cervical disc disease causing neck pain, weakness, or numbness that hasn't improved with treatments like rest or physical therapy. It's not for those who are very overweight, have had certain spine surgeries before, smoke heavily, have osteoporosis, metal allergies, immobile spinal segments, autoimmune diseases affecting the musculoskeletal system or take medication that affects healing.Check my eligibility
What is being tested?
The study compares two types of artificial cervical discs (prodisc C SK and Vivo) against a similar approved device (Mobi-C). Participants will be randomly assigned to receive one of these devices in a surgery meant to alleviate symptoms from degenerative disc conditions in the neck.See study design
What are the potential side effects?
Potential side effects may include discomfort at the implant site, infection risk from surgery, allergic reactions to materials in the implants if sensitivity exists despite screening out known allergies during eligibility assessment and possible complications related to movement of the artificial disc.

SMART Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have nerve pain or weakness in my neck affecting my arms or hands.
Select...
My symptoms match the findings on my imaging tests.
Select...
I have neck pain due to issues in my cervical spine at two levels between C3 and C7.
Select...
I am between 18 and 69 years old.
Select...
I have nerve pain or weakness in my neck affecting my arms, due to issues between C3 and C7.
Select...
I am between 18 and 69 years old.
Select...
My symptoms match the findings on my imaging tests.

SMART Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Composite clinical success rate of the two-level prodisc C SK and prodisc C Vivo will be no worse than marketed cervical disc prosthesis (Mobi-C)

Side effects data

From 2014 Phase 3 trial • 600 Patients • NCT01801735
6%
Urinary tract infection
6%
Arthralgia
100%
80%
60%
40%
20%
0%
Study treatment Arm
Meloxicam 10 mg

SMART Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InvestigationalExperimental Treatment1 Intervention
Two-level prodisc C SK and/or prodisc C Vivo
Group II: ControlActive Control1 Intervention
Two-level Mobi-C device

Find a Location

Who is running the clinical trial?

Centinel SpineLead Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled
Leonard I Voronov, MD, PhDStudy DirectorCentinel Spine
James KurasStudy DirectorCentinel Spine

Media Library

prodisc C SK (Artificial Disc Replacement) Clinical Trial Eligibility Overview. Trial Name: NCT04012996 — N/A
Cervical Disc Disease Research Study Groups: Investigational, Control
Cervical Disc Disease Clinical Trial 2023: prodisc C SK Highlights & Side Effects. Trial Name: NCT04012996 — N/A
prodisc C SK (Artificial Disc Replacement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04012996 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How widely dispersed is the implementation of this research endeavor?

"This research is available to patients at Northwell Health Lenox Hill Hospital in New york, William Beaumont Hospital in Royal Oak, Michigan and Texas Spine Care in San Antonio, as well as 36 other sites."

Answered by AI

Is this investigation currently seeking participants?

"Data hosted on clinicaltrials.gov confirms that this experiment remains open for recruitment, having first been posted on August 5th 2019 and most recently updated October 27th 2022."

Answered by AI

What are the eligibility criteria for enrolment in this clinical trial?

"This clinical trial is seeking 390 individuals aged 18 to 69 that have been diagnosed with intervertebral disc displacement. Moreover, to be eligible for the study, these patients must have undergone a non-surgical course of treatment and present radiographic evidence of pathology at the symptomatic level in their cervical spine (C3 - C7)."

Answered by AI

Is eligibility contingent on a participant's age, such that those over 20 years are excluded?

"This experiment is open to individuals aged between 18 and 69. There are also two trials specifically for minors, as well as 91 studies that cater exclusively to seniors older than 65 years old."

Answered by AI

How many participants has the research accepted to date?

"Affirmative, clinicaltrials.gov states that this research is actively seeking volunteers. It was first published on August 5th 2019 and updated most recently on October 27th 2022. As of then, 390 participants had to be recruited from 36 different sites."

Answered by AI

Who else is applying?

What state do they live in?
California
Ohio
Nebraska
Other
How old are they?
18 - 65
What site did they apply to?
Flagstaff Bone and Joint
Doctors Outpatient Center for Surgery
Penn State Milton S. Hershey Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
~69 spots leftby Apr 2025